NCT00004877View on ClinicalTrials.gov

BMS-214662 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Primary Completion Date

April 30, 2001

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

BMS-214662

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00004877 - BMS-214662 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter